Shanghai Bao Pharmaceuticals Co., Ltd. (HKG:2659)
17.60
-0.87 (-4.71%)
Jul 30, 2026, 4:08 PM HKT
HKG:2659 Market Cap
HKG:2659 has a market cap or net worth of 6.02 billion as of July 30, 2026.
Market Cap
6.02B
Enterprise Value
4.99B
Revenue
54.70M
Ranking
n/a
PE Ratio
n/a
Stock Price
17.60
ChartMarket Cap Chart
Since December 10, 2025, HKG:2659's market cap has decreased from 20.54B to 6.02B, a decrease of -70.68%. That is a compound annual growth rate of -85.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 6.02B | -76.18% |
| Dec 31, 2025 | 25.28B | 23.10% |
| Dec 10, 2025 | 20.54B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Everest Medicines | 8.72B |
| Suzhou Ribo Life Science | 8.51B |
| Lepu Biopharma | 8.28B |
| CARsgen Therapeutics Holdings | 7.84B |
| Alphamab Oncology | 7.69B |
| Abbisko Cayman | 7.42B |
| Shanghai Haohai Biological Technology | 7.23B |
| LongBio Pharma (Suzhou) | 7.20B |